Beauty Health misses Q1 revenue estimates, cuts FY revenue forecast

Skinhealth Systems

07/05/2026 21:54

Overview

US medical aesthetics firm's Q1 revenue fell 6.7% yr/yr, missing analyst expectations

Adjusted EBITDA for Q1 rose and beat analyst estimates, driven by lower operational spend

Company cut full-year revenue outlook amid continued pressure on device sales

Outlook

Company lowers 2026 full-year net sales outlook to $280–$295 mln

Company expects Q2 net sales of $72–$77 mln

Company sees continued pressure on year-over-year device sales

Result Drivers

LOWER DEVICE AND CONSUMABLE SALES - Co said Q1 revenue decline was due to lower delivery systems and consumables sales

REDUCED OPERATING EXPENSES - Co attributed improved adjusted EBITDA to lower personnel-related and marketing expenses

ONGOING MARKET CHALLENGES - Co cited continued pressure on device sales and challenging market conditions

Company press release: ID:nGNX5lQTn8

Key Details

Metric
Beat/Miss
Actual
Consensus Estimate
Q1 Sales
Miss
$64.90 mln
$66.45 mln (8 Analysts)
Q1 Net Income
-$6.60 mln
Q1 Adjusted EBITDA
$8.50 mln
Q1 Adjusted Gross Margin
72.20%


Analyst Coverage

The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 1 "strong buy" or "buy", 6 "hold" and 2 "sell" or "strong sell"

The average consensus recommendation for the personal products peer group is "buy."

Wall Street's median 12-month price target for Skinhealth Systems Inc is $1.43, about 52.8% above its May 6 closing price of $0.93

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)